Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.